de Hoog M - Search Results

1

The effect of critical illness and inflammation on midazolam therapy in children.

Vet NJ, de Hoog M, Tibboel D, de Wildt SN. Vet NJ, et al. Among authors: de wildt sn, de hoog m. Pediatr Crit Care Med. 2012 Jan;13(1):e48-50. doi: 10.1097/PCC.0b013e3181fe406d. Pediatr Crit Care Med. 2012. PMID: 21057365

2

Unapproved and off-label use of drugs in a children's hospital.

't Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. 't Jong GW, et al. Among authors: de hoog m. N Engl J Med. 2000 Oct 12;343(15):1125. doi: 10.1056/NEJM200010123431515. N Engl J Med. 2000. PMID: 11032528 No abstract available.

3

A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.

't Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. 't Jong GW, et al. Among authors: de hoog m. Pediatrics. 2001 Nov;108(5):1089-93. doi: 10.1542/peds.108.5.1089. Pediatrics. 2001. PMID: 11694685 Free article.

4

Serial measurements of energy expenditure in critically ill children: useful in optimizing nutritional therapy?

de Klerk G, Hop WC, de Hoog M, Joosten KF. de Klerk G, et al. Among authors: de hoog m. Intensive Care Med. 2002 Dec;28(12):1781-5. doi: 10.1007/s00134-002-1523-z. Epub 2002 Oct 17. Intensive Care Med. 2002. PMID: 12447523

5

Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.

de Wildt SN, de Hoog M, Vinks AA, van der Giesen E, van den Anker JN. de Wildt SN, et al. Among authors: de hoog m. Crit Care Med. 2003 Jul;31(7):1952-8. doi: 10.1097/01.ccm.0000084806.15352.da. Crit Care Med. 2003. PMID: 12847388

6

Assessment of sedation levels in pediatric intensive care patients can be improved by using the COMFORT "behavior" scale.

Ista E, van Dijk M, Tibboel D, de Hoog M. Ista E, et al. Among authors: de hoog m. Pediatr Crit Care Med. 2005 Jan;6(1):58-63. doi: 10.1097/01.PCC.0000149318.40279.1A. Pediatr Crit Care Med. 2005. PMID: 15636661

7

Pharmacodynamics of midazolam in pediatric intensive care patients.

de Wildt SN, de Hoog M, Vinks AA, Joosten KF, van Dijk M, van den Anker JN. de Wildt SN, et al. Among authors: de hoog m. Ther Drug Monit. 2005 Feb;27(1):98-102. doi: 10.1097/00007691-200502000-00018. Ther Drug Monit. 2005. PMID: 15665754 Clinical Trial.

8

Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin.

Brevoord JC, Joosten KF, Arts WF, van Rooij RW, de Hoog M. Brevoord JC, et al. Among authors: de hoog m. J Child Neurol. 2005 Jun;20(6):476-81. doi: 10.1177/08830738050200060201. J Child Neurol. 2005. PMID: 15996395 Clinical Trial.

9

Information technology cannot guarantee patient safety.

de Wildt SN, Verzijden R, van den Anker JN, de Hoog M. de Wildt SN, et al. Among authors: de hoog m. BMJ. 2007 Apr 21;334(7598):851-2. doi: 10.1136/bmj.39104.625903.80. BMJ. 2007. PMID: 17446618 Free PMC article. Review.

10

Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. "Assessment remains troublesome".

Ista E, van Dijk M, Gamel C, Tibboel D, de Hoog M. Ista E, et al. Among authors: de hoog m. Intensive Care Med. 2007 Aug;33(8):1396-406. doi: 10.1007/s00134-007-0696-x. Epub 2007 Jun 1. Intensive Care Med. 2007. PMID: 17541548 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters